Kdl Biotech
(Become first to Rate this Company!)
|
|
KDL Biotech was incorporated on August 12, 1986. The company has a biotechnology division, which manufactures Penicillin-G acylase, the enzyme used for conversion of penicillin to 6APA. It has also successfully developed Bleomycin, an anti-cancer drug and a cytoxic antibiotic. The products under development include mitomycin, another anti-cancer drug and Vancomycin, an anti- bacterial. The company is also one of the largest manufacturers of semi synthetic penicillin in Asia.
KDL Biotech is public limited and is listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
Below you will find details about KDL Biotech Company Profile, Share Price, News, Address, Management, Registrar and Contact Details.
|
|
|
Indutry Type
|
|
|
|
|
Year of Incorporation
|
|
1986
|
|
|
Registered Address
|
|
Village Savroli,
Taluka: Khalapur,
Raigad - 410202
Maharashtra
Tel: 02192-274026 02192-274027
Fax: 02192-274031
|
|
|
Corporate Contact Details
|
|
|
|
|
Company Registrar
|
|
Big Share Services Pvt. Ltd. E/2, E/3, Ansa Industrial Estate
Saki Vihar Road
Sakinaka, Andheri (E)
Tel: 022-28470652, 28470653, 28473474, 40430200
Fax: 022-28475207, 28525207
|
|
|
Company Management
|
|
Name : Designation
Nalin Bamzai : Managing Director
Sanjay Sinha : Director
Yogendra Kumar Chauhan : Director
Name : Designation
Rajesh Agrawal : Director (Technical)
Tushar Kumar Srivastava : Director
|
|
|
Jobs
|
|
|
|
|
